Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 18 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 10123529

    Compounds for protection of cells

    Sulfateq B.V. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  2. US 10117899

    Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells

    Sangamo Therapeutics, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  3. US 10106620

    Blocking CD38 using anti-CD38 F(ab′)2 to protect NK cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  4. US 10105392

    Isolated renal cells and uses thereof

    inRegen · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  5. US 10098847

    Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  6. US 10100279

    In vitro production of medial ganglionic eminence precursor cells

    The Regents of the University of California · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  7. US 10093899

    Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

    Precision BioSciences, Inc. · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted
  8. US 10093900

    Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

    Precision BioSciences, Inc. · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted
  9. US 10087232

    Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy

    Protalix Ltd. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  10. US 10080730

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    United Therapeutics Corporation · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  11. US 10077424

    Methods of producing RPE cells and compositions of RPE cells

    Astellas Institute for Regenerative Medicine · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  12. US 10076545

    Pharmaceutically compatible method for purifying intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  13. US 10077442

    Bioactive renal cells

    inRegen · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  14. US 10072243

    Derivation of embryonic stem cells and embryo-derived cells

    Astellas Institute for Regenerative Medicine · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  15. US 10071123

    Treatment of pulmonary arterial hypertension with mesenchymal stem cells

    United Therapeutics Corporation · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  16. US 10058572

    Placenta-derived multipotent stem cells

    The Regents of the University of California · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted
  17. US 10052363

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted
  18. US 10046012

    Multipotent postnatal stem cells from human periodontal ligament and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  19. US 10046010

    Methods of generating mesenchymal stem cells which secrete neurotrophic factors

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  20. US 10041936

    Neuronal cells cultured on microparticles and methods of using same

    The Regents of the University of California · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  21. US 10034916

    Methods of treating a retinal disease by retinal pigment epithelial stem cells

    REGENERATIVE RESEARCH FOUNDATION · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted
  22. US 10035823

    Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflammatory diseases and conditions

    The Regents of the University of California · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted
  23. US 10023879

    Minimal volume reprogramming of mononuclear cells

    Fate Therapeutics, Inc. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted
  24. US 10016463

    Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

    United Therapeutics Corporation · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted